Celldex Therapeutics SG&A Expense Quarterly:
3.138M for March 31, 2013Celldex Therapeutics Historical SG&A Expense Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 3.138M |
| Dec. 31, 2012 | 2.644M |
| Sept. 30, 2012 | 2.835M |
| June 30, 2012 | 2.219M |
| March 31, 2012 | 2.317M |
| Dec. 31, 2011 | 2.344M |
| Sept. 30, 2011 | 2.273M |
| June 30, 2011 | 2.24M |
| March 31, 2011 | 2.336M |
| Dec. 31, 2010 | 2.53M |
| Sept. 30, 2010 | 2.421M |
| June 30, 2010 | 2.591M |
| March 31, 2010 | 2.835M |
| Dec. 31, 2009 | 6.418M |
| Sept. 30, 2009 | 3.85M |
| June 30, 2009 | 3.511M |
| March 31, 2009 | 3.341M |
| Dec. 31, 2008 | 2.922M |
| Sept. 30, 2008 | 4.206M |
| June 30, 2008 | 4.606M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About SG&A Expense
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
The details of how SG&A expenses are calculated vary widely from company to company, so YCharts recommends looking at the annual report (10-k) an investor is interested in dissecting this number further.
Learn More
CLDX SG&A Expense Quarterly Benchmarks
| Companies | |
|---|---|
| Ariad Pharmaceuticals | 29.48M |
| Array BioPharma | 5.001M |
| Insmed | 3.61M |
CLDX SG&A Expense Quarterly Rankings
| Overall |
49th percentile 3864 of 7590 |
| Sector |
40th percentile 385 of 651 in Healthcare |
| Industry |
57th percentile 102 of 238 in Biotechnology |
CLDX SG&A Expense Quarterly Range, Past 5 Years
| Minimum | 2.219M | Jun 2012 |
| Maximum | 6.418M | Dec 2009 |
| Average | 3.079M |
